156 related articles for article (PubMed ID: 31919500)
41. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
[TBL] [Abstract][Full Text] [Related]
42. Transcervical Extended Mediastinal Lymphadenectomy: Experience From a North American Cancer Center.
Yendamuri S; Battoo A; Dy G; Chen H; Gomez J; Singh AK; Hennon M; Nwogu CE; Dexter EU; Huang M; Picone A; Demmy TL
Ann Thorac Surg; 2017 Nov; 104(5):1644-1649. PubMed ID: 28942077
[TBL] [Abstract][Full Text] [Related]
43. Role of surgical resection for patients with limited disease-small cell lung cancer.
Takenaka T; Takenoyama M; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Lung Cancer; 2015 Apr; 88(1):52-6. PubMed ID: 25662387
[TBL] [Abstract][Full Text] [Related]
44. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
45. Primary synchronous small and non-small cell lung cancer in the same lung lobe: A case report.
Dzian A; Ivan F; Zdenko H; Peter S
Monaldi Arch Chest Dis; 2017 Dec; 87(3):797. PubMed ID: 29424199
[TBL] [Abstract][Full Text] [Related]
46. A recurrence-free survivor with chemotherapy-refractory small cell lung cancer after pneumonectomy: A case report and review of the literature.
Pan Y; Kong FW; Wang H; Wang X; Zhang H; Wu WB; Zhang M
Medicine (Baltimore); 2017 Nov; 96(47):e8922. PubMed ID: 29382030
[TBL] [Abstract][Full Text] [Related]
47. Heterogeneity of clinical n1 non-small cell lung cancer.
Kim D; Choi YS; Kim HK; Kim K; Kim J; Shim YM
Thorac Cardiovasc Surg; 2014 Mar; 62(2):103-8. PubMed ID: 23319312
[TBL] [Abstract][Full Text] [Related]
48. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
49. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
51. Surgical outcomes of early-stage small-cell lung cancer: single-center experience.
Sayan M; Satir Turk M; Celik A; Cuneyt Kurul I; Irfan Tastepe A
Asian Cardiovasc Thorac Ann; 2019 Mar; 27(3):187-191. PubMed ID: 30661378
[TBL] [Abstract][Full Text] [Related]
52. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
[TBL] [Abstract][Full Text] [Related]
53. [The role of surgical resection in treating small cell lung cancer].
Ye B; Zhao SH; Liu XY
Ai Zheng; 2007 Jul; 26(7):795-7. PubMed ID: 17626763
[TBL] [Abstract][Full Text] [Related]
54. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
[TBL] [Abstract][Full Text] [Related]
55. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
56. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
57. Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
Woo JH; Kim MY; Lee KS; Jeong DY; Chung MJ; Han J; Shim YM
AJR Am J Roentgenol; 2019 Apr; 212(4):773-781. PubMed ID: 30673331
[TBL] [Abstract][Full Text] [Related]
58. Surgical intervention for small-cell lung cancer: what is the surgical role?
Inoue M; Sawabata N; Okumura M
Gen Thorac Cardiovasc Surg; 2012 Jul; 60(7):401-5. PubMed ID: 22638740
[TBL] [Abstract][Full Text] [Related]
59. Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.
Qiao R; Zhong R; Xu J; Zhang Y; Zhang B; Wang S; Lou Y; Chen D; Chang Q; Zhao Y; Han B
J Cardiothorac Surg; 2019 Mar; 14(1):63. PubMed ID: 30925891
[TBL] [Abstract][Full Text] [Related]
60. Subcarinal Lymph Nodes Should be Dissected in All Lobectomies for Non-Small Cell Lung Cancer-Regardless of Primary Tumor Location.
Eckardt J; Jakobsen E; Licht PB
Ann Thorac Surg; 2017 Apr; 103(4):1121-1125. PubMed ID: 28109572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
